DK137690D0 - Pyrimidinyl-substituerede hydroxysyrer, lactoner og estere - Google Patents

Pyrimidinyl-substituerede hydroxysyrer, lactoner og estere

Info

Publication number
DK137690D0
DK137690D0 DK137690A DK137690A DK137690D0 DK 137690 D0 DK137690 D0 DK 137690D0 DK 137690 A DK137690 A DK 137690A DK 137690 A DK137690 A DK 137690A DK 137690 D0 DK137690 D0 DK 137690D0
Authority
DK
Denmark
Prior art keywords
lactons
pyrimidinyl
esters
hydroxy acids
substituted hydroxy
Prior art date
Application number
DK137690A
Other languages
English (en)
Other versions
DK137690A (da
Inventor
Faizulla Gulamhusein Kathawala
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK137690D0 publication Critical patent/DK137690D0/da
Publication of DK137690A publication Critical patent/DK137690A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK137690A 1988-10-06 1990-06-01 Pyrimidinyl-substituerede hydroxysyrer, lactoner og estere DK137690A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25451488A 1988-10-06 1988-10-06
PCT/EP1989/000225 WO1990003973A1 (en) 1988-10-06 1989-03-06 Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
DK137690D0 true DK137690D0 (da) 1990-06-01
DK137690A DK137690A (da) 1990-06-01

Family

ID=22964577

Family Applications (1)

Application Number Title Priority Date Filing Date
DK137690A DK137690A (da) 1988-10-06 1990-06-01 Pyrimidinyl-substituerede hydroxysyrer, lactoner og estere

Country Status (9)

Country Link
EP (1) EP0367895A1 (da)
JP (1) JPH03501613A (da)
KR (1) KR900701778A (da)
AU (1) AU3214689A (da)
DK (1) DK137690A (da)
IL (1) IL89542A0 (da)
PH (1) PH26675A (da)
WO (1) WO1990003973A1 (da)
ZA (1) ZA891696B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832570A1 (de) * 1988-09-24 1990-03-29 Hoechst Ag 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
FR2670211B1 (fr) * 1990-12-11 1993-01-22 Rhone Poulenc Sante Procede de preparation de derives de l'acide dihydroxy-3,5 oxo-6 hexanouique.
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
EP0705837B1 (en) 1994-09-06 2002-08-07 Ube Industries, Ltd. Preparation of 3-Oxy-5-oxo-6-heptenoic acid derivatives
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
AR034772A1 (es) 2001-07-13 2004-03-17 Astrazeneca Uk Ltd Preparacion de los compuestos de aminopirimidina
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
ATE448209T1 (de) 2002-12-16 2009-11-15 Astrazeneca Uk Ltd Verfahren zur herstellung von pyrimidinverbindungen
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
US7371759B2 (en) 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
JPWO2012046772A1 (ja) 2010-10-06 2014-02-24 国立大学法人 東京大学 リンパ浮腫予防治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3823045A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag 3-desmethyl-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung sowie zwischenprodukte
EP0308736A3 (en) * 1987-09-12 1990-02-14 Nissan Chemical Industries Ltd. Pyrimidine type mevalonolactones

Also Published As

Publication number Publication date
EP0367895A1 (en) 1990-05-16
ZA891696B (en) 1990-11-28
WO1990003973A1 (en) 1990-04-19
PH26675A (en) 1992-09-15
AU3214689A (en) 1990-05-01
KR900701778A (ko) 1990-12-04
IL89542A0 (en) 1989-09-10
DK137690A (da) 1990-06-01
JPH03501613A (ja) 1991-04-11

Similar Documents

Publication Publication Date Title
NO910295D0 (no) Hyaluronsyre-estere og fremgangsmaate derav.
IT8847963A0 (it) Esteri polisaccaridici
FI894573L (fi) Belaeggningsfoerfarande.
DK137690A (da) Pyrimidinyl-substituerede hydroxysyrer, lactoner og estere
DK131087A (da) 1,2,3,4-tetrahydro-6-substitueret-4-aryl-(eller -heterocyclo-)-3-substitueret-2-thioxo-/eller -oxo)-5-pyrimidincarboxylsyrer og estere
DE68904753D1 (de) Kaeltemittelbehandlungs- und fuellsystem.
DE3861876D1 (de) Vollformverfahren und -vorrichtung.
DK555289D0 (da) Fermenteringsfremgangsmaade
DE3887709D1 (de) Anzeigevorrichtung und -verfahren.
DE3888588D1 (de) Phenylalkenylcarbonsäuren und deren Ester.
NO890264L (no) Nye aminosyreestere og fremgangsmaate for fremstilling derav.
NO931011D0 (no) 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -estere
NL8601645A (nl) 3-(gesubstitueerde)propenylaminothiazolyl-cefalosporanzuren en esters daarvan.
NO894399L (no) Optisk aktive benzoksasiner og benzotiaziner.
DE58902314D1 (de) Substituierte acrylsaeureester.
IT1226386B (it) Procedimento di preparazione di morniflumato e analoghi.
FI883771A7 (fi) 3-(substituoitu) propenyyli-7 -(aminotiatsolyyliasetamido) -kef-3-eemi-4-karboksyylihappoja sekä niiden estereitä.
NO883897L (no) 4-okso-3-kinolinkarboksylsyrer og deres fremstilling.
ATE90466T1 (de) Kassierverfahren und -vorrichtung.
FI910470A0 (fi) Regel.
NO895099L (no) Heteroatom-inneholdende perfluoralkylterminerte neopentylsyrer og salter derav.
NO894670D0 (no) Tetrametylpiperidyl-avsluttede triazin-oligomere estere og amider.
NO891653L (no) Aminosyreestere og deres fremstilling.
DK501989D0 (da) Mikrobiocidt praeparat og dettes fremstilling
NO890522D0 (no) Substituerte imidazolinoner og imidazolinthioner.